About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company working to advance safe and efficient injectable treatments for patients across oncology, critical care, and orphan diseases. Their business model is to develop proprietary innovations to FDA-approved, injectable drugs, that offer commercial and/or functional advantages to currently available alternatives.

Public
Pharmaceuticals
2007
United States
Woodcliff Lake, New Jersey
12013265300
investors@eagleus.com
NASDAQ
EGRX

Annual Revenue

$50 to $500 million

Employees

51-200

Eagle Pharmaceuticals, Inc. Contacts

We have 121 contacts in our database, out of which 45% are decision makers. The distribution of leads are as follows:

Classification of Eagle Pharmaceuticals, Inc. Contacts as per Designation Label:
Classification of Eagle Pharmaceuticals, Inc. Contacts by Functional Responsibility (Top 5):

Eagle Pharmaceuticals, Inc. Website Traffic Analysis

In October, 2019 eagleus.com's total website visitor was 6266, None. Some key metrics are Average time spent on site is 0 minutes, Bounce Rate is 90% and average page per visit is 1 respectively.

Site Traffic by Month
Traffic Sources
Geographic Breakdown
Average Visitor Per Month Icon
2504
Time Spend Icon
0 Minutes
Bounce Rate Icon
90%
Page Per Visit Icon
1

Frequently Asked Question About Eagle Pharmaceuticals, Inc.

1. Eagle Pharmaceuticals, Inc. was founded in 2007.
2. Eagle Pharmaceuticals, Inc. specialize in Drug Development, Treatment For Oncology, Bendamustine Hydrochloride Injection, Dantrolene Sodium Injectable Suspension.
3. $50 to $500 million.
4. 51-200 employees.
5. Eagle Pharmaceuticals, Inc. is a Public company.
6. Eagle Pharmaceuticals, Inc. headquarter located in Woodcliff Lake New Jersey, United States.
7. We have 121 contacts in our database.
8. We have 54 decision makers in our database.

Flash News

  • Firehouse
  • Firehouse
  • Firehouse
  • Firehouse
  • Firehouse
  • Firehouse
  • Firehouse
  • Firehouse
  • Firehouse
  • Firehouse